In vitro activity of HR 810, a new cephalosporin.
AUTOR(ES)
Bertram, M A
RESUMO
The in vitro susceptibility of 409 clinical isolates to HR 810, a new cephalosporin, was evaluated and compared with their susceptibility to aztreonam, cefazolin, ceftazidime, imipenem, moxalactam, piperacillin, and gentamicin. On a weight basis, the activity of HR 810 against gram-negative bacilli was equivalent or superior to that of the other beta-lactam agents except imipenem.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=284139Documentos Relacionados
- In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.
- In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.
- In Vitro Evaluation of HR810, a New Wide-Spectrum Aminothiazolyl α-Methoxyimino Cephalosporin
- In vitro activity of DQ-2556, a new cephalosporin.
- In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
